Sarepta Therapeutics shares are trading lower after RBC Capital downgraded the stock from Outperform to Sector Perform.
Portfolio Pulse from Benzinga Newsdesk
Sarepta Therapeutics shares are trading lower following a downgrade by RBC Capital from Outperform to Sector Perform.
May 28, 2024 | 1:15 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Sarepta Therapeutics shares are trading lower after RBC Capital downgraded the stock from Outperform to Sector Perform.
The downgrade by RBC Capital is likely to negatively impact investor sentiment and lead to a short-term decline in Sarepta Therapeutics' stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100